<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04128280</url>
  </required_header>
  <id_info>
    <org_study_id>2019-307</org_study_id>
    <nct_id>NCT04128280</nct_id>
  </id_info>
  <brief_title>Multi-center Clinical Observation of a New Treatment Method Based on the Pathogenesis of Obstructive Prostatitis</brief_title>
  <official_title>Multi-center Clinical Observation of a New Treatment Method Based on the Pathogenesis of Obstructive Prostatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sir Run Run Shaw Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xin Hua Hospital of Zhejiang Province</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huashan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Shanxi Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital of Qingdao University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multi-center clinical observation of a new treatment method based on the pathogenesis of
      obstructive prostatitis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Study purpose: To investigate the therapeutic effect of transurethral dilation of
           prostate with a columnar balloon on patients with chronic obstructive prostatitis

        2. Study design: A randomized, controlled, multi-center clinical trial

        3. Study subjects: Patients with chronic obstructive prostatitis

        4. Number of subjects: 180

        5. Surgery treatments:

      Test group: Patients will receive a surgery: transurethral dilation of prostate with a
      columnar balloon.

      Control group: Patients will receive a surgery: transurethral incision of bladder neck.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The score of CPSI</measure>
    <time_frame>within 12 months after surgery</time_frame>
    <description>measure the chronic prostatitis symptom index (CPSI) by a questionnaire</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Chronic Prostatitis</condition>
  <arm_group>
    <arm_group_label>Test Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test group: Patients will receive a surgery: transurethral dilation of prostate with a columnar balloon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control group: Patients will receive a surgery: transurethral incision of bladder neck.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TUDP</intervention_name>
    <description>a surgery: transurethral dilation of prostate with a columnar balloon</description>
    <arm_group_label>Test Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TUIB</intervention_name>
    <description>a surgery: transurethral incision of bladder neck</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. older than 35 years old, urinary obstruction is clear;

          2. the total score of chronic prostatitis symptoms index (CPSI) is greater than 14
             points, and the severity of symptoms is greater than 9 points;

          3. maximum urine flow rate is less than 15 ml/s;

          4. cystoscopy and pathological biopsy confirmed the presence of bladder neck fibrosis,
             bladder trabeculae formation;

          5. other conservative treatments are ineffective or ineffective, and drug treatment is
             not effective for more than 6 months;

          6. voluntarily participated in this clinical trial, complied with the requirements of
             this study and signed the informed consent form.

        Exclusion Criteria:

          1. urinary tract infection, urinary tumor, history of intestinal inflammatory disease;

          2. neurogenic bladder;

          3. history of pelvic radiation therapy or chemotherapy;

          4. PSA is abnormal;

          5. urethral stricture, history of bladder or prostate surgery;

          6. the investigator determined that it is not suitable for this clinical trial.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shigeng Zhang, Dr.</last_name>
    <phone>+86-571-87783550</phone>
    <email>zsg710728@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Second Affiliated Hospital, School of Medicine, Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shigeng Zhang, Dr.</last_name>
      <phone>+86-571-87783550</phone>
      <email>zsg710728@zju.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 14, 2019</study_first_submitted>
  <study_first_submitted_qc>October 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2019</study_first_posted>
  <last_update_submitted>May 9, 2020</last_update_submitted>
  <last_update_submitted_qc>May 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Prostatitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

